Pacira | PCRX - Stammkapital

Aktienkurs
22.46
Täglich Wechseln
0.35 1.58%
Monatlich
-4.06%
Jährlich
-9.58%
Q1 Prognose
21.45




Stammkapital Veränderung Datum
Assertio Holdings USD 9K 0 2023-12
Astellas Pharma JPY 1.79B 195K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 2K 3K 2025-03
Coherus Biosciences USD 121.16M 4.92M 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 584K 2025-09
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Novo Nordisk DKK 4.44B 0 2025-12
Omeros USD 611K 17K 2023-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Xoma USD 87K 1000 2024-06
Zoetis USD 424.93M 16.54M 2025-12